Results 151 to 160 of about 25,888 (267)

Acute neural effects of selective serotonin reuptake inhibitors versus noradrenaline reuptake inhibitors on emotion processing: Implications for differential treatment efficacy [PDF]

, 2013
Andrew Kemp
core   +1 more source

The effect of serotonin reuptake and serotonin-noradrenaline reuptake inhibitors on motor symptoms in Parkinson’s disease

Soavtorji: Martijn Hendriks, R Saman Vinke, Aleksander Sadikov and Dejan Georgiev.
Matić, Teodora, Hendriks, Martijn, Vinke, Ruben Saman, Sadikov, Aleksander, računalništvo, Georgiev, Dejan   +4 more
openaire   +1 more source

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

British Journal of Clinical Pharmacology, Volume 92, Issue 5, Page 1287-1308, May 2026.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou, Georgia Valsami, Georgios Ismailos   +2 more
wiley   +1 more source

Pharmacogenomics of Major Depressive Disorder in Indigenous Amazonian Populations

Clinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1331-1339, May 2026.
Major depressive disorder is a highly prevalent psychological disorder worldwide and its main treatment is the use of Selective Serotonin Reuptake Inhibitors. However, few studies have demonstrated the relationship between the presence of genetic variants in pharmacogenes and the efficacy of these drugs, especially in populations with a unique genetic ...
Kaio Evandro Cardoso Aguiar, Natasha Monte da Silva, Juliana Carla Gomes Rodrigues, André Maurício Ribeiro‐dos‐Santos, Sandro José de Souza, Ândrea Ribeiro‐dos‐Santos, João Farias Guerreiro, Sidney Emanuel Batista dos Santos, Marianne Rodrigues Fernandes, Ney Pereira Carneiro dos Santos   +9 more
wiley   +1 more source

Efficacy of Dextromethorphan Augmentation in SSRI‐Resistant Obsessive–Compulsive Disorder: A Randomized Controlled Trial

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims Obsessive–compulsive disorder (OCD) is a chronic condition associated with marked functional impairment and high rates of treatment resistance. Converging evidence implicates glutamatergic dysregulation in OCD pathophysiology.
Ahmad Zolghadriha, Afagh Anjomshoaa, Romina Bagheri   +2 more
wiley   +1 more source

FIGO best practice recommendations for the mental health of women at menopausal age

International Journal of Gynecology &Obstetrics, Volume 173, Issue 2, Page 588-601, May 2026.
Abstract Mental health during the menopausal transition requires focused attention to ensure supportive experiences for women. This review presents the International Federation of Gynecology and Obstetrics (FIGO) recommendations and summarizes the evidence, addressing 13 key questions framed by members of the FIGO Committee on Women at Menopausal Age ...
Suvarna Khadilkar, Hema Divakar, Chiara Benedetto, Andrea Genazzani, Diana Ramos, Elizabete Argale, Gandhali Deshpande, Martha Hicky, Agnaldo Lopes Da Silva Filho, Enrique Herrera, Milan Balkrishnan   +10 more
wiley   +1 more source

ADHD medications and drug withdrawal: A pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
Takumi Ebina, Kunihiro Iwamoto, Masashi Ikeda   +2 more
wiley   +1 more source

Out‐of‐Pocket Costs and Antidepressant Adherence in Head and Neck Cancer Survivors

Psycho-Oncology, Volume 35, Issue 5, May 2026.
ABSTRACT Background Head and neck cancer (HNC) survivors have a high burden of depression, yet real‐world antidepressant adherence and the role of patient out‐of‐pocket (OOP) costs in this population remain poorly characterized. Methods We analyzed a retrospective cohort of US adults with HNC and a new antidepressant prescription in Merative MarketScan
Gennaro Di Tosto, Neil K. Mehta, Christopher W. Noel, Ann Scheck McAlearney, Lauren E. Miller   +4 more
wiley   +1 more source

Savella® (Milnacipran) Causing Elevated Normetanephrines [PDF]

, 2019
Bhattacharya, Rajib K., Miles, John M., Yehya, Ahmad   +2 more
core   +2 more sources

Unveiling the Demographics and Clinical Characteristics of Diabetic Neuropathy: Findings From the National Health Insurance Service, 2012–2017

Journal of Diabetes, Volume 18, Issue 5, May 2026.
Diabetic neuropathy prevalence declined from 23.4% to 21.5% between 2012 and 2017. About half received treatment, mainly α‐lipoic acid monotherapy; patients were older with comorbidities, leading to more hospitalizations. ABSTRACT Background Diabetic neuropathy (DN) is the most common chronic complication of Type 2 diabetes mellitus (T2DM), with ...
Su Jin Jeong, Sun Keun Kim, Chong Hwa Kim   +2 more
wiley   +1 more source